CONTINGENT PAYMENT (Details Narrative) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
USD ($)
| |
| CONTINGENT PAYMENT | |
| Net sales and profit sharing | $ 400,000 |
| Upfront purchase price | $ 400,000 |
| Seller for purchase of assets description | until such amounts equal $400,000 of 50% of the Net Sales (as defined in the APA) of Lucemyra and 50% of the Net Distributable Profits (as defined in the APA) of the generic version of Lucemyra. The Company shall also pay to the Seller a royalty equal to 3% of the Net Sales of Lucemyra and 3% of the Net Distributable Profits of the generic version of Lucemyra on a calendar quarter basis |
| Royalty payments period | 5 years |